These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11212879)

  • 1. Adenoviral p53 gene therapy promotes heat-induced apoptosis in a nasopharyngeal carcinoma cell line.
    Qi V; Weinrib L; Ma N; Li JH; Klamut H; Liu FF
    Int J Hyperthermia; 2001; 17(1):38-47. PubMed ID: 11212879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of combining ionizing radiation and adenoviral p53 therapy in nasopharyngeal carcinoma.
    Li JH; Lax SA; Kim J; Klamut H; Liu FF
    Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):607-16. PubMed ID: 10078646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin chemotherapy plus adenoviral p53 gene therapy in EBV-positive and -negative nasopharyngeal carcinoma.
    Weinrib L; Li JH; Donovan J; Huang D; Liu FF
    Cancer Gene Ther; 2001 May; 8(5):352-60. PubMed ID: 11477455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic effects of Ad5CMV-p53 expression in two human nasopharyngeal carcinoma cell lines.
    Li JH; Li P; Klamut H; Liu FF
    Clin Cancer Res; 1997 Apr; 3(4):507-14. PubMed ID: 9815713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.
    Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ
    J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additional gene therapy with Ad5CMV-p53 enhanced the efficacy of radiotherapy in human prostate cancer cells.
    Sasaki R; Shirakawa T; Zhang ZJ; Tamekane A; Matsumoto A; Sugimura K; Matsuo M; Kamidono S; Gotoh A
    Int J Radiat Oncol Biol Phys; 2001 Dec; 51(5):1336-45. PubMed ID: 11728695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy of adenoviral-mediated p53 gene transfer is synergistically enhanced by combined use of antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model.
    Miyake H; Yamanaka K; Muramaki M; Hara I; Gleave ME
    Neoplasia; 2005 Feb; 7(2):171-9. PubMed ID: 15802022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenoviral-mediated gene therapy with Ad5CMVp53 and Ad5CMVp21 in combination with standard therapies in human breast cancer cell lines.
    Parker LP; Wolf JK; Price JE
    Ann Clin Lab Sci; 2000 Oct; 30(4):395-405. PubMed ID: 11045764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic antitumor effect of combined use of adenoviral-mediated p53 gene transfer and antisense oligodeoxynucleotide targeting clusterin gene in an androgen-independent human prostate cancer model.
    Yamanaka K; Gleave ME; Hara I; Muramaki M; Miyake H
    Mol Cancer Ther; 2005 Feb; 4(2):187-95. PubMed ID: 15713890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p16 gene therapy: a potentially efficacious modality for nasopharyngeal carcinoma.
    Lee AW; Li JH; Shi W; Li A; Ng E; Liu TJ; Klamut HJ; Liu FF
    Mol Cancer Ther; 2003 Oct; 2(10):961-9. PubMed ID: 14578461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined radiation and p53 gene therapy of malignant glioma cells.
    Badie B; Goh CS; Klaver J; Herweijer H; Boothman DA
    Cancer Gene Ther; 1999; 6(2):155-62. PubMed ID: 10195882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy for bladder cancer using adenoviral vector.
    Wada Y; Gotoh A; Shirakawa T; Hamada K; Kamidono S
    Mol Urol; 2001; 5(2):47-52. PubMed ID: 11690547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced therapeutic efficacy of adenovirus-mediated interleukin-24 gene therapy combined with ionizing radiotherapy for nasopharyngeal carcinoma.
    Liu J; Zhang Y; Sun P; Xie Y; Xiang J; Yang J
    Oncol Rep; 2013 Sep; 30(3):1165-74. PubMed ID: 23783436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic chemosensitization and inhibition of tumor growth and metastasis by adenovirus-mediated P53 gene transfer in human bladder cancer model.
    Miyake H; Hara I; Hara S; Arakawa S; Kamidono S
    Urology; 2000 Aug; 56(2):332-6. PubMed ID: 10925118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenoviral p53 gene transfer in human bladder cancer cell lines: cytotoxicity and synergy with cisplatin.
    Pagliaro LC; Keyhani A; Liu B; Perrotte P; Wilson D; Dinney CP
    Urol Oncol; 2003; 21(6):456-62. PubMed ID: 14693272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p21WAF1/CIP1 is more effective than p53 in growth suppression of mouse renal carcinoma cell line Renca in vitro and in vivo.
    Kralj M; Pavelić J
    J Cancer Res Clin Oncol; 2003 Aug; 129(8):463-71. PubMed ID: 12884025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
    Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis induced in human osteosarcoma cells is one of the mechanisms for the cytocidal effect of Ad5CMV-p53.
    Wang J; Bucana CD; Roth JA; Zhang WW
    Cancer Gene Ther; 1995 Mar; 2(1):9-17. PubMed ID: 7621257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Chloroethyl-3-sarcosinamide-1-nitrosourea (SarCNU) exhibits p53-dependent and -independent antiproliferative activity in human nasopharyngeal carcinoma cells in vitro and in vivo.
    Nguyen TH; Ong CK; Wong E; Leong CT; Panasci L; Huynh H
    Int J Oncol; 2005 Oct; 27(4):1131-40. PubMed ID: 16142332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical study of adenoviral p53 gene therapy for esophageal cancer.
    Shimada H; Shimizu T; Ochiai T; Liu TL; Sashiyama H; Nakamura A; Matsubara H; Gunji Y; Kobayashi S; Tagawa M; Sakiyama S; Hiwasa T
    Surg Today; 2001; 31(7):597-604. PubMed ID: 11495154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.